ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.9083
0.01%
Brent Oil
82.275
-0.71%
Bitcoin
62,421.13
0.14%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aligos Therapeutics Inc (ALGS)

  7. Aligos Therapeutics Inc (ALGS) Noticias

ALGS Aligos Therapeutics Inc

0.79
0.00 (0.00%)
Pre Mercado
Última actualización: 03:05:16
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aligos Therapeutics Inc ALGS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.79 03:05:16
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.79
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/5/202415:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202415:05EDGAR2Form 8-K - Current report
07/5/202415:05GLOBEAligos Therapeutics Reports Recent Business Progress..
30/4/202415:05GLOBEAligos Therapeutics to Announce 1st Quarter 2024 Financial..
25/4/202415:05GLOBEAligos Therapeutics Presents Positive Clinical Data at..
25/4/202407:00GLOBEAligos Therapeutics Mourns the Passing of MASH Industry..
09/4/202407:00GLOBEAligos Therapeutics to Participate in the Piper Sandler..
03/4/202407:00GLOBEAligos Therapeutics Announces First Subjects Dosed in the..
27/3/202407:00GLOBEAligos Therapeutics Presents Positive Clinical Data at APASL..
18/3/202407:00GLOBEAligos Therapeutics Announces the Initiation of the Phase 2a..
12/3/202415:05GLOBEAligos Therapeutics Reports Recent Business Progress..
05/3/202415:05GLOBEAligos Therapeutics to Announce 4th Quarter 2023 Financial..
04/3/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202407:00GLOBEAligos Therapeutics To Participate in the Leerink Partners..
20/2/202407:00GLOBEAligos Therapeutics to Host KOL Event to Discuss Phase 2a..
13/2/202407:00GLOBEAligos Therapeutics Strengthens Finance Leadership Team with..
30/1/202406:04EDGAR2Form SC TO-I - Tender offer statement by Issuer
25/1/202405:12EDGAR2Form SC TO-C - Written communication relating to an issuer..
25/1/202405:06EDGAR2Form 8-K - Current report
28/11/202315:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/11/202315:05EDGAR2Form 8-K - Current report
17/11/202315:38EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202315:01EDGAR2Form 8-K - Current report
07/11/202311:03EDGAR2Form D - Notice of Exempt Offering of Securities
02/11/202315:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202315:05EDGAR2Form 8-K - Current report
25/10/202316:05EDGAR2Form 8-K - Current report
18/10/202307:45EDGAR2Form 8-K - Current report
12/9/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202315:01EDGAR2Form 8-K - Current report
03/8/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:05EDGAR2Form 8-K - Current report
01/8/202315:52EDGAR2Form 8-K - Current report
25/7/202315:02EDGAR2Form 8-K - Current report
21/7/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
ALGS
Aligos Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados